EUVIMEDEUVIMED entdecken
Leserbrief

Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression

Yao Liu iD, Yibing Liu iD

Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3667-3668

DOI: 10.1111/jgh.70788 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 01.10.2026. Verfasst von Yao Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Medical University, Shijiazhuang, China. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Autor:innen und Institutionen

  • Hebei Medical University, Shijiazhuang, China.
  • Department of Medicine Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

ORCID-Profile: Yao Liu, Yibing Liu

Zitieren

APA

Liu, Y., & Liu, Y. (2026). Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression. Journal of Gastroenterology and Hepatology, 41(11), 3667-3668. https://doi.org/10.1111/jgh.70788

Vancouver

Liu Y, Liu Y. Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression. Journal of Gastroenterology and Hepatology. 2026;41(11):3667-3668. doi:10.1111/jgh.70788

BibTeX
@article{Liu2026,
  author = {Liu, Yao and Liu, Yibing},
  title = {Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {3667--3668},
  doi = {10.1111/jgh.70788}
}
Kostenlos starten →